The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333), which would reauthorize the Hospital Preparedness Program at the current funding level of $385 million through fiscal year 2029. Among other provisions, the bill would require drug makers to notify the Food and Drug Administration when they anticipate a meaningful shortage and report who makes the active pharmaceutical ingredients in their drugs. AHA has urged Congress to at least double current annual funding for the HPP, which it called “vastly insufficient,” as well as address drug and device shortages.

Related News Articles

Headline
The Administration for Strategic Preparedness and Response is seeking public feedback on its Hospital Preparedness Program funding formula. The HPP is the…
Headline
In this AHA blog Aisha Syeda, senior program manager for AHA’s Strategic Initiatives, summarizes five action steps hospitals can take to establish pediatric…
Blog
In 2024, the U.S. suffered 24 weather and climate disasters. In October alone, two major hurricanes devastated communities in North Carolina and Florida,…
Headline
Reports of cases of pertussis, also known as whooping cough, are currently five times higher compared to last year, according to the Centers for Disease…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Disease Control and Prevention Oct. 25 announced additional reported cases of E. coli from individuals who ate at McDonald's prior to falling…